2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Jin, M; Kashida, Y; Mitsumori, K; Moto, M; Muguruma, M; Okamura, M | 1 |
| Ban, H; Donehower, LA; Hirata, A; Masegi, T; Sakai, H; Takasu, S; Tatematsu, M; Tsukamoto, T; Yamamoto, M; Yanai, T | 1 |
2 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and Diathesis
| Article | Year |
|---|---|
A 26-week carcinogenicity study of 2-amino-3-methylimidazo[4,5-f]quinoline in rasH2 mice.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Carcinoma, Hepatocellular; Disease Susceptibility; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Hyperplasia; Liver Neoplasms, Experimental; Male; Mice; Mice, Transgenic; Neoplasms; Papilloma; Quinolines; Stomach Neoplasms; Time Factors | 2006 |
Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).
Topics: Animals; Carcinogenicity Tests; Carcinogens; Carcinoma, Squamous Cell; Disease Susceptibility; Female; Genes, p53; Liver Neoplasms, Experimental; Male; Mice; Mice, Knockout; Mutation; Organ Specificity; Quinolines; Stomach Neoplasms; Time Factors | 2007 |